Clinical Trial Update: Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum [NA]

View source ↗

Summary

A completed clinical trial evaluating transcutaneous electrical acupoint stimulation (TEAS) for liver and kidney dysfunction after pneumoperitoneum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Dysfunction
• Renal Dysfunction

Snippet

Sponsor: Zhihong LU | Conditions: Hepatic Dysfunction Transient, Renal Function Disorder | NA | Status: COMPLETED